Dr. Yuying (Kate) You advises life sciences and biotechnology clients on complex intellectual property strategy, offering pragmatic and business-aligned counsel to support innovation and commercialization. She partners with in-house teams to develop robust patent strategies tailored to evolving technologies and competitive landscapes, with a focus on maximizing long-term portfolio value and practical outcomes.

Kate has deep experience in advising on a broad spectrum of technologies, including cell therapy (such as CAR-T, TCR-T, NK, Treg), gene therapy, biologics, cancer therapeutics, metabolic modulators, in vivo delivery vehicles and strategies, circular RNA, and diagnostics/prognostics. She is experienced in portfolio building, balancing strategic strength, commercial priorities, and lifecycle planning.

Prior to joining the firm, Dr. Kate You was postdoctoral fellow at Stanford University, School of Medicine, Department of Neurology, where she worked on multiple clinical research projects, established several international and domestic collaborations, and developed a novel diagnostic assay for an autoimmune neurological disease. During her Ph.D. study at University of Alabama at Birmingham in the department of microbiology, Dr. You conducted two research projects on basic immunology, both published in peer-review journals. Dr. You received the Hiramoto Travel Award and was invited to orally present her findings at three international conferences.

Dr. You was co-president of the Chinese Life-Science Postdocs and Students at Stanford for a year and president at the Chinese American BioPharmaceutical Society (CABS).

Dr. You earned her J.D. at University of California, in Los Angeles, CA, her  Ph.D. in microbiology/immunology from the University of Alabama in Birmingham, AL and her B.S. in biology from the Fudan University in Shanghai, China.

Dr. You is admitted in California and is fluent in Mandarin.